Norbolethone
Grundinformationen
- CAS
1235-15-0- Standard-SMILES
CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC- InChIKey
FTBJKONNNSKOLX-XUDSTZEESA-N- Summenformel
- C21H32O2
- Durchschnittliche Molmasse
- 316,5 g/mol
Überblick
norbolethone is a DEA Schedule III controlled substance. Substances in the DEA Schedule III have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. It is a Anabolic steroids substance.
Namen und Bezeichner
- Bevorzugter Name
- Norbolethone
- IUPAC
- (8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- Englischer Name
- (8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- Summenformel
- C21H32O2
- Molmasse
- 316.48
Namen und Synonyme
NORBOLETHONEGenabol1235-15-0NorbolhetoneWY-347513-EHDPOU3BZU2241ADTXSID5015402713-ethyl-17-hydroxy-18,19-dinor-17-pregn-4-en-20-yn-3-one(1S,2R,10R,11S,14S,15S)-14,15-diethyl-14-hydroxytetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-6-en-5-one(1S,2R,10R,11S,14S,15S)-14,15-diethyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-oneRefChem:927894
Weitere Namen anzeigen
3-Ethyl-17-hydroxy-18,19-dinor-pregn-4-en-3-one(17S)-13ξ-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-3-oneDl-13-beta,17-alpha-diethyl-17-beta-hydroxygon-4-en-3-one18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17α)-(±)-(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
DTXCID401473668Norboletone797-58-0DL-NorbolethoneNorboletone [INN]NorboletonaWy 3475Norbolethone [USAN]
Datenbank-Bezeichner
- CAS
1235-15-0、797-58-0- PubChem CID
- 66255
- DTXSID
DTXSID50154027- ChEMBL
CHEMBL2105134- UNII
- O60979L83F、U3BZU2241A
- Nikkaji
- J69.163A
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,8
- Polarare Oberfläche (TPSA)
- 37,3 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 2
- Schwere Atome
- 23
- Formalladung
- 0
- Komplexität
- 536
Experimentelle und physikochemische Eigenschaften
Drugs
DEA Schedule III Controlled Substance -> Anabolic steroids
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Endocrine DisruptorsPotential endocrine disrupting compound
Physical DescriptionSolid
Physikochemische Eigenschaften
- Schmelzpunkt
- 144 · 144-145°
- Siedepunkt
- 459.5 · 459.5±45.0 °C(Predicted)
- Dichte
- 1.09 · 1.09±0.1 g/cm3(Predicted)
- Löslichkeit
- soluble in Chloroform, Methanol
- Aggregatzustand
- Solid
- pka
- 15.13 · 15.13±0.40(Predicted)
- Farbe
- Pale Beige
Sicherheit und Regulatorisches
Gefahrenhinweise
Regulatory InformationDEA schedule III controlled substance
Sicherheitsdaten
- Toxizität
- LD50 orally in mice: >5010 mg/kg (Goldenthal)
- DEA Controlled Substances
- CSCN: 4000CSA SCH: Schedule IIINARC: No
Chemie und Industrie
Pharmakologische Informationen
Cellular LocationsExtracellular
Anwendungen
VerwendenAn anabolic steroid which encourages weight gain. Controlled Substance
Anbieter3 Anbieter
艾吉析科技（上海）有限公司17721401538;17717235263 17721401538 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
Shaanxi Dideu Medichem Co. Ltd+86-17392712779 · [email protected]
Zugehörige Reaktionen
2
Notizen zur Verbindung
Wird geladen…